Evidence map›Paper›PMID 36804150›Full record

ArticleThe Journal of investigative dermatology2023

Improving Artificial Intelligence-Based Diagnosis on Pediatric Skin Lesions.

Paras P Mehta, Mary Sun, Brigid Betz-Stablein, Allan Halpern, H Peter Soyer, Jochen Weber, Kivanc Kose, Veronica Rotemberg

Abstract read
In one paragraph

Article in The Journal of investigative dermatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Paras P MehtaDivision of Dermatology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA. Electronic address: pmehta2016@gmail.com.
Mary SunDivision of Dermatology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Brigid Betz-StableinDermatology Research Centre, The University of Queensland Diamantina Institute, Brisbane, Australia.
Allan HalpernDivision of Dermatology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
H Peter SoyerDermatology Research Centre, The University of Queensland Diamantina Institute, Brisbane, Australia.
Jochen WeberDivision of Dermatology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Kivanc KoseDivision of Dermatology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Veronica RotembergDivision of Dermatology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Clinical and Translational Science AwardUL1TR001873 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI REILLY, MUREDACH P · 2016 to 2025
$99.0M
Disparities in COVID Disease Severity and Outcomes in New York CityUL1TR002384 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI JULIANNE L IMPERATO-MCGINLEY · 2017 to 2026
$86.2M
Institutional Career Development CoreKL2TR002385 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI YUAN-SHAN ZHU · 2017 to 2026
$13.3M
M-ISIC: A Multimodal Open-Source International Skin Imaging Collaboration Informatics Platform for Automated Skin Cancer DetectionU24CA264369 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI Kivanc Kose, Veronica Miriam Rotemberg · 2022 to 2026
$3.9M
ISIC-REPO; ISIC Skin Imaging Repository Enhancements for Promoting Interoperability and UtilizationU24CA285296 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ALLAN C HALPERN, Kivanc Kose · 2024 to 2026
$2.1M
NCATS NIH HHS KL2 TR002385NCATS NIH HHS UL1 TR001873NCATS NIH HHS UL1 TR002384NCI NIH HHS P30 CA008748NCI NIH HHS U24 CA264369NCI NIH HHS U24 CA285296
6 · The paper itself

Abstract

Artificial intelligence algorithms to classify melanoma are dependent on their training data, which limits generalizability. The objective of this study was to compare the performance of an artificial intelligence model trained on a standard adult-predominant dermoscopic dataset before and after the addition of additional pediatric training images. The performances were compared using held-out adult and pediatric test sets of images. We trained two models: one (model A) on an adult-predominant dataset (37,662 images from the International Skin Imaging Collaboration) and the other (model A+P) on an additional 1,536 pediatric images. We compared performance between the two models on adult and pediatric held-out test images separately using the area under the receiver operating characteristic curve. We then used Gradient-weighted Class Activation Maps and background skin masking to understand the contributions of the lesion versus background skin to algorithm decision making. Adding images from a pediatric population with different epidemiological and visual patterns to current reference standard datasets improved algorithm performance on pediatric images without diminishing performance on adult images. This suggests a way that dermatologic artificial intelligence models can be made more generalizable. The presence of background skin was important to the pediatric-specific improvement seen between models. Our study highlights the importance of carefully curated and labeled data from diverse inputs to improve the generalizability of AI models for dermatology, in this case applied to dermoscopic images of adult and pediatric lesions to improve melanoma detection.

Indexed as

MelanomaSkin DiseasesSkin NeoplasmsAdultArtificial IntelligenceChildHumansSkin

Identifiers

PMID36804150
PMCPMC10431965

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.